{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T15:14:32Z","timestamp":1767971672963,"version":"3.49.0"},"reference-count":200,"publisher":"Portland Press Ltd.","issue":"19","content-domain":{"domain":["portlandpress.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,10,16]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The virulence of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and the aggressive nature of the disease has transformed the universal pace of research in the desperate attempt to seek effective therapies to halt the morbidity and mortality of this pandemic. The rapid sequencing of the SARS-CoV-2 virus facilitated identification of the receptor for angiotensin converting enzyme 2 (ACE2) as the high affinity binding site that allows virus endocytosis. Parallel evidence that coronavirus disease 2019 (COVID-19) disease evolution shows greater lethality in patients with antecedent cardiovascular disease, diabetes, or even obesity questioned the potential unfavorable contribution of angiotensin converting enzyme (ACE) inhibitors or angiotensin II (Ang II) receptor blockers as facilitators of adverse outcomes due to the ability of these therapies to augment the transcription of Ace2 with consequent increase in protein formation and enzymatic activity. We review, here, the specific studies that support a role of these agents in altering the expression and activity of ACE2 and underscore that the robustness of the experimental data is associated with weak clinical long-term studies of the existence of a similar regulation of tissue or plasma ACE2 in human subjects.<\/jats:p>","DOI":"10.1042\/cs20200901","type":"journal-article","created":{"date-parts":[[2020,10,16]],"date-time":"2020-10-16T09:12:30Z","timestamp":1602839550000},"page":"2645-2664","update-policy":"https:\/\/doi.org\/10.1042\/crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Twenty years of progress in angiotensin converting enzyme 2 and its link to SARS-CoV-2 disease"],"prefix":"10.1042","volume":"134","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0792-6239","authenticated-orcid":false,"given":"Carlos\u00a0M.","family":"Ferrario","sequence":"first","affiliation":[{"name":"Departments of Surgery and Physiology-Pharmacology, Wake Forest School of Medicine, Winston-Salem, NC 27157, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarfaraz","family":"Ahmad","sequence":"additional","affiliation":[{"name":"Department of Surgery, Wake Forest School of Medicine, Winston-Salem, NC 27157, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Groban","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology, Wake Forest School of Medicine, Winston-Salem, NC 27157, U.S.A."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"288","published-online":{"date-parts":[[2020,10,16]]},"reference":[{"key":"2021113011163418200_B1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1186\/1743-422X-2-73","article-title":"The SARS coronavirus S glycoprotein receptor binding domain: fine mapping and functional characterization","volume":"2","author":"Chakraborti","year":"2005","journal-title":"Virol. J"},{"key":"2021113011163418200_B2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.virol.2006.01.029","article-title":"Identification of critical determinants on ACE2 for SARS-CoV entry and development of a potent entry inhibitor","volume":"350","author":"Han","year":"2006","journal-title":"Virology"},{"key":"2021113011163418200_B3","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1038\/nature02145","article-title":"Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus","volume":"426","author":"Li","year":"2003","journal-title":"Nature"},{"key":"2021113011163418200_B4","first-page":"260","article-title":"Cloning of ACE-2 gene encoding the functional receptor for the SARS coronavirus and its expression in eukaryotic cells","volume":"19","author":"Lu","year":"2005","journal-title":"Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi"},{"key":"2021113011163418200_B5","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/978-0-387-33012-9_48","article-title":"Human angiotensin-converting enzyme 2 (ACE2) is a receptor for human respiratory coronavirus NL63","volume":"581","author":"Smith","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021113011163418200_B6","first-page":"450","article-title":"Mice transgenic for human angiotensin-converting enzyme 2 provide a model for SARS coronavirus infection","volume":"57","author":"Yang","year":"2007","journal-title":"Comp. Med."},{"key":"2021113011163418200_B7","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1007\/978-0-387-33012-9_93","article-title":"Identification of ferret ACE2 and its receptor function for SARS-coronavirus","volume":"581","author":"Zamoto","year":"2006","journal-title":"Adv. Exp. Med. Biol."},{"key":"2021113011163418200_B8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.compbiolchem.2005.04.008","article-title":"A molecular docking model of SARS-CoV S1 protein in complex with its receptor, human ACE2","volume":"29","author":"Zhang","year":"2005","journal-title":"Comput. Biol. Chem."},{"key":"2021113011163418200_B9","doi-asserted-by":"publisher","first-page":"33238","DOI":"10.1074\/jbc.M002615200","article-title":"A human homolog of angiotensin-converting enzyme. Cloning and functional expression as a captopril-insensitive carboxypeptidase","volume":"275","author":"Tipnis","year":"2000","journal-title":"J. Biol. Chem."},{"key":"2021113011163418200_B10","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem. J."},{"key":"2021113011163418200_B11","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0165-6147(00)01994-5","article-title":"The angiotensin-converting enzyme gene family: genomics and pharmacology","volume":"23","author":"Turner","year":"2002","journal-title":"Trends Pharmacol. Sci."},{"key":"2021113011163418200_B12","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1139\/y02-021","article-title":"ACEH\/ACE2 is a novel mammalian metallocarboxypeptidase and a homologue of angiotensin-converting enzyme insensitive to ACE inhibitors","volume":"80","author":"Turner","year":"2002","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"2021113011163418200_B13","doi-asserted-by":"publisher","first-page":"14040","DOI":"10.1073\/pnas.0506735102","article-title":"Severe acute respiratory syndrome coronavirus-like virus in Chinese horseshoe bats","volume":"102","author":"Lau","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011163418200_B14","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1007\/s11357-020-00198-w","article-title":"COVID-19-associated cardiovascular morbidity in older adults: a position paper from the Italian Society of Cardiovascular Researches","volume":"4","author":"Moccia","year":"2020","journal-title":"Geroscience"},{"key":"2021113011163418200_B15","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1093\/cvr\/cvaa078","article-title":"The ACE2 expression in human heart indicates new potential mechanism of heart injury among patients infected with SARS-CoV-2","volume":"6","author":"Chen","year":"2020","journal-title":"Cardiovasc. Res."},{"issue":"11","key":"2021113011163418200_B16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China","volume":"323","author":"Wang","year":"2020","journal-title":"JAMA"},{"key":"2021113011163418200_B17","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the Lombardy region, Italy","volume":"323","author":"Grasselli","year":"2020","journal-title":"JAMA"},{"key":"2021113011163418200_B18","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11906-020-01073-x","article-title":"Is sex a determinant of COVID-19 infection? Truth or myth?","volume":"22","author":"Groban","year":"2020","journal-title":"Curr. Hypertens. Rep."},{"key":"2021113011163418200_B19","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1186\/1471-2164-8-194","article-title":"Identification and characterisation of the angiotensin converting enzyme-3 (ACE3) gene: a novel mammalian homologue of ACE","volume":"8","author":"Rella","year":"2007","journal-title":"BMC Genomics"},{"key":"2021113011163418200_B20","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1161\/01.HYP.35.1.480","article-title":"Gender differences in development of hypertension in spontaneously hypertensive rats: role of the renin-angiotensin system","volume":"35","author":"Reckelhoff","year":"2000","journal-title":"Hypertension"},{"key":"2021113011163418200_B21","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1111\/j.1440-1681.2007.04643.x","article-title":"Sex differences in oxidative stress and the impact on blood pressure control and cardiovascular disease","volume":"34","author":"Sartori-Valinotti","year":"2007","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113011163418200_B22","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1161\/HYPERTENSIONAHA.107.106922","article-title":"Sex differences in the pressor response to angiotensin II when the endogenous renin-angiotensin system is blocked","volume":"51","author":"Sartori-Valinotti","year":"2008","journal-title":"Hypertension"},{"key":"2021113011163418200_B23","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1042\/CS20070169","article-title":"Endothelin, sex and hypertension","volume":"114","author":"Tostes","year":"2008","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011163418200_B24","doi-asserted-by":"publisher","DOI":"10.2807\/1560-7917.ES.2020.25.22.2001010","article-title":"SARS-CoV-2-related paediatric inflammatory multisystem syndrome, an epidemiological study, France, 1 March to 17 May 2020","volume":"25","author":"Belot","year":"2020","journal-title":"Euro Surveill."},{"key":"2021113011163418200_B25","doi-asserted-by":"publisher","first-page":"m2094","DOI":"10.1136\/bmj.m2094","article-title":"Kawasaki-like multisystem inflammatory syndrome in children during the covid-19 pandemic in Paris, France: prospective observational study","volume":"369","author":"Toubiana","year":"2020","journal-title":"BMJ"},{"key":"2021113011163418200_B26","doi-asserted-by":"publisher","DOI":"10.3949\/ccjm.87a.ccc039","article-title":"New spectrum of COVID-19 manifestations in children: Kawasaki-like syndrome and hyperinflammatory response","author":"Panupattanapong","year":"2020","journal-title":"Cleve. Clin. J. Med."},{"key":"2021113011163418200_B27","doi-asserted-by":"publisher","first-page":"1517","DOI":"10.1111\/jth.14844","article-title":"Pathological evidence of pulmonary thrombotic phenomena in severe COVID-19","volume":"18","author":"Dolhnikoff","year":"2020","journal-title":"J. Thromb. Haemost."},{"key":"2021113011163418200_B28","doi-asserted-by":"publisher","first-page":"3184","DOI":"10.1016\/j.jacc.2020.05.008","article-title":"COVID-19, clinical trials and QT-prolonging prophylactic therapy in healthy subjects: first, do no harm","volume":"75","author":"Gollob","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"2021113011163418200_B29","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1042\/CS20200163","article-title":"Soluble angiotensin-converting enzyme 2: a potential approach for coronavirus infection therapy?","volume":"134","author":"Batlle","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"issue":"3","key":"2021113011163418200_B30","doi-asserted-by":"publisher","DOI":"10.1093\/jtm\/taaa041","article-title":"Hypothesis: angiotensin-converting enzyme inhibitors and angiotensin receptor blockers may increase the risk of severe COVID-19","volume":"37","author":"Diaz","year":"2020","journal-title":"J. Travel Med."},{"issue":"4","key":"2021113011163418200_B31","doi-asserted-by":"publisher","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"2021113011163418200_B32","doi-asserted-by":"publisher","first-page":"H2281","DOI":"10.1152\/ajpheart.00618.2005","article-title":"Advances in biochemical and functional roles of angiotensin-converting enzyme 2 and angiotensin-(1-7) in regulation of cardiovascular function","volume":"289","author":"Ferrario","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011163418200_B33","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1161\/01.HYP.30.3.535","article-title":"Counterregulatory actions of angiotensin-(1-7)","volume":"30","author":"Ferrario","year":"1997","journal-title":"Hypertension"},{"key":"2021113011163418200_B34","doi-asserted-by":"publisher","first-page":"224","DOI":"10.2174\/1871528113666140713164506","article-title":"ACE and ACE2 in inflammation: a tale of two enzymes","volume":"13","author":"Gaddam","year":"2014","journal-title":"Inflamm. Allergy Drug Targets"},{"key":"2021113011163418200_B35","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s11064-018-2679-4","article-title":"ACE2 in brain physiology and pathophysiology: evidence from transgenic animal models","volume":"44","author":"Alenina","year":"2019","journal-title":"Neurochem. Res."},{"key":"2021113011163418200_B36","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1161\/01.HYP.0000196268.08909.fb","article-title":"Angiotensin-converting enzyme 2 and angiotensin-: an evolving story in cardiovascular regulation","volume":"47","author":"Ferrario","year":"2006","journal-title":"Hypertension"},{"key":"2021113011163418200_B37","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/MNH.0b013e3283406f57","article-title":"ACE2: more of Ang-(1-7) or less Ang II?","volume":"20","author":"Ferrario","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113011163418200_B38","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1152\/physrev.00023.2016","article-title":"The ACE2\/Angiotensin-(1-7)\/MAS axis of the renin-angiotensin system: focus on Angiotensin-(1-7)","volume":"98","author":"Santos","year":"2018","journal-title":"Physiol. Rev."},{"key":"2021113011163418200_B39","first-page":"125","article-title":"Role of the vasodilator peptide angiotensin-(1-7) in cardiovascular drug therapy","volume":"3","author":"Schindler","year":"2007","journal-title":"Vasc. Health Risk Manag."},{"key":"2021113011163418200_B40","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Simoes e Silva","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"2021113011163418200_B41","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/s41569-020-0369-9","article-title":"Reply to: \u2018Interaction between RAAS inhibitors and ACE2 in the context of COVID-19\u2019","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"2021113011163418200_B42","doi-asserted-by":"publisher","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"2021113011163418200_B43","doi-asserted-by":"crossref","first-page":"16518","DOI":"10.1016\/S0021-9258(19)84737-3","article-title":"Identification of angiotensin-(1-7) in rat brain. Evidence for differential processing of angiotensin peptides","volume":"264","author":"Chappell","year":"1989","journal-title":"J. Biol. Chem."},{"key":"2021113011163418200_B44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1016\/0196-9781(87)90084-2","article-title":"Characterization by high performance liquid chromatography of angiotensin peptides in the plasma and cerebrospinal fluid of the dog","volume":"8","author":"Chappell","year":"1987","journal-title":"Peptides"},{"key":"2021113011163418200_B45","first-page":"107","article-title":"A hypothesis regarding the function of angiotensin peptides in the brain","volume":"10","author":"Ferrario","year":"1988","journal-title":"Clin. Exp. Hypertens. A"},{"key":"2021113011163418200_B46","doi-asserted-by":"publisher","first-page":"I153","DOI":"10.1161\/01.HYP.11.2_Pt_2.I153","article-title":"Converting enzyme activity and angiotensin metabolism in the dog brainstem","volume":"11","author":"Santos","year":"1988","journal-title":"Hypertension"},{"key":"2021113011163418200_B47","doi-asserted-by":"publisher","first-page":"4095","DOI":"10.1073\/pnas.85.11.4095","article-title":"Release of vasopressin from the rat hypothalamo-neurohypophysial system by angiotensin-(1-7) heptapeptide","volume":"85","author":"Schiavone","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"key":"2021113011163418200_B48","doi-asserted-by":"publisher","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"2021113011163418200_B49","doi-asserted-by":"publisher","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hydrolysis of biological peptides by human angiotensin-converting enzyme-related carboxypeptidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"2021113011163418200_B50","doi-asserted-by":"publisher","first-page":"1535","DOI":"10.1016\/j.lfs.2005.07.026","article-title":"Effect of hypertension on angiotensin-(1-7) levels in rats with different angiotensin-I converting enzyme polymorphism","volume":"78","author":"Ocaranza","year":"2006","journal-title":"Life Sci."},{"key":"2021113011163418200_B51","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril attenuates downregulation of Angiotensin-converting enzyme 2 in the late phase of ventricular dysfunction in myocardial infarcted rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"2021113011163418200_B52","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1093\/eurheartj\/ehi114","article-title":"Myocardial infarction increases ACE2 expression in rat and humans","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"2021113011163418200_B53","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1007\/978-1-4939-6625-7_8","article-title":"Measurement of angiotensin converting enzyme 2 activity in biological fluid (ACE2)","volume":"1527","author":"Xiao","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"2021113011163418200_B54","doi-asserted-by":"publisher","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of angiotensin-converting enzyme inhibition and angiotensin II receptor blockers on cardiac angiotensin-converting enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"2021113011163418200_B55","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1097\/MNH.0b013e328341164a","article-title":"Angiotensin-converting enzyme 2 is a key modulator of the renin-angiotensin system in cardiovascular and renal disease","volume":"20","author":"Tikellis","year":"2011","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113011163418200_B56","doi-asserted-by":"publisher","first-page":"30113","DOI":"10.1074\/jbc.M505111200","article-title":"Tumor necrosis factor-alpha convertase (ADAM17) mediates regulated ectodomain shedding of the severe-acute respiratory syndrome-coronavirus (SARS-CoV) receptor, angiotensin-converting enzyme-2 (ACE2)","volume":"280","author":"Lambert","year":"2005","journal-title":"J. Biol. Chem."},{"key":"2021113011163418200_B57","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/j.bbadis.2004.05.005","article-title":"Interaction of ACE2 and integrin beta1 in failing human heart","volume":"1689","author":"Lin","year":"2004","journal-title":"Biochim. Biophys. Acta"},{"key":"2021113011163418200_B58","doi-asserted-by":"publisher","first-page":"2704","DOI":"10.1007\/s00018-004-4240-7","article-title":"Angiotensin-converting enzyme-2: a molecular and cellular perspective","volume":"61","author":"Warner","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"2021113011163418200_B59","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.taap.2016.06.026","article-title":"Activation of angiotensin-converting enzyme 2 (ACE2) attenuates allergic airway inflammation in rat asthma model","volume":"306","author":"Dhawale","year":"2016","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021113011163418200_B60","doi-asserted-by":"crossref","first-page":"820.2","DOI":"10.1096\/fasebj.31.1_supplement.820.2","article-title":"Apelin increases airway reactivity and inflammation in a mouse model of asthma","volume":"31","author":"Dholakia","year":"2017","journal-title":"FASEB J."},{"key":"2021113011163418200_B61","doi-asserted-by":"publisher","first-page":"259","DOI":"10.2174\/1566524019666191028122559","article-title":"Dynorphins in development and disease: implications for cardiovascular disease","volume":"20","author":"Cissom","year":"2020","journal-title":"Curr. Mol. Med."},{"key":"2021113011163418200_B62","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2020.01.001","article-title":"Dynorphin and Enkephalin opioid peptides and transcripts in spinal cord and dorsal root ganglion during peripheral inflammatory hyperalgesia and allodynia","author":"Sapio","year":"2020","journal-title":"J. Pain"},{"key":"2021113011163418200_B63","first-page":"e35","article-title":"Prevalence of underlying diseases in hospitalized patients with COVID-19: a systematic review and meta-analysis","volume":"8","author":"Emami","year":"2020","journal-title":"Arch. Acad. Emerg. Med."},{"key":"2021113011163418200_B64","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nature00786","article-title":"Angiotensin-converting enzyme 2 is an essential regulator of heart function","volume":"417","author":"Crackower","year":"2002","journal-title":"Nature"},{"key":"2021113011163418200_B65","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/path.1570","article-title":"Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis","volume":"203","author":"Hamming","year":"2004","journal-title":"J. Pathol."},{"key":"2021113011163418200_B66","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.2174\/138161207780618911","article-title":"The two fACEs of the tissue renin-angiotensin systems: implication in cardiovascular diseases","volume":"13","author":"Lazartigues","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"2021113011163418200_B67","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.placenta.2005.02.015","article-title":"Distribution of angiotensin-(1-7) and ACE2 in human placentas of normal and pathological pregnancies","volume":"27","author":"Valdes","year":"2006","journal-title":"Placenta"},{"key":"2021113011163418200_B68","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1161\/01.HYP.0000085220.53285.11","article-title":"Enhanced renal immunocytochemical expression of ANG-(1-7) and ACE2 during pregnancy","volume":"42","author":"Brosnihan","year":"2003","journal-title":"Hypertension"},{"key":"2021113011163418200_B69","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1113\/expphysiol.2005.031096","article-title":"Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats","volume":"90","author":"Huentelman","year":"2005","journal-title":"Exp. Physiol."},{"key":"2021113011163418200_B70","doi-asserted-by":"publisher","first-page":"H3019","DOI":"10.1152\/ajpheart.01198.2006","article-title":"Primary role of angiotensin-converting enzyme-2 in cardiac production of angiotensin-(1-7) in transgenic Ren-2 hypertensive rats","volume":"292","author":"Trask","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011163418200_B71","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1038\/ajh.2010.51","article-title":"Inhibition of angiotensin-converting enzyme 2 exacerbates cardiac hypertrophy and fibrosis in Ren-2 hypertensive rats","volume":"23","author":"Trask","year":"2010","journal-title":"Am. J. Hypertens."},{"key":"2021113011163418200_B72","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.coph.2010.12.002","article-title":"ACE2, a promising therapeutic target for pulmonary hypertension","volume":"11","author":"Shenoy","year":"2011","journal-title":"Curr. Opin. Pharmacol."},{"key":"2021113011163418200_B73","doi-asserted-by":"publisher","first-page":"529","DOI":"10.2337\/db09-1218","article-title":"Human recombinant ACE2 reduces the progression of diabetic nephropathy","volume":"59","author":"Oudit","year":"2010","journal-title":"Diabetes"},{"key":"2021113011163418200_B74","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1042\/CS20110668","article-title":"Interaction of diabetes and ACE2 in the pathogenesis of cardiovascular disease in experimental diabetes","volume":"123","author":"Tikellis","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011163418200_B75","doi-asserted-by":"publisher","first-page":"F1374","DOI":"10.1152\/ajprenal.00656.2011","article-title":"Differential regulation of circulating and renal ACE2 and ACE in hypertensive mRen2.Lewis rats with early-onset diabetes","volume":"302","author":"Yamaleyeva","year":"2012","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B76","doi-asserted-by":"publisher","first-page":"421","DOI":"10.3109\/00365513.2015.1054871","article-title":"Urinary ACE2 is associated with urinary L-FABP and albuminuria in patients with chronic kidney disease","volume":"75","author":"Abe","year":"2015","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"2021113011163418200_B77","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.atherosclerosis.2016.08.032","article-title":"Circulating angiotensin converting enzyme 2 activity as a biomarker of silent atherosclerosis in patients with chronic kidney disease","volume":"253","author":"Anguiano","year":"2016","journal-title":"Atherosclerosis"},{"issue":"7-8","key":"2021113011163418200_B78","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1007\/s12471-020-01439-5","article-title":"Renin-angiotensin system inhibition in COVID-19 patients","volume":"28","author":"de Vries","year":"2020","journal-title":"Neth. Heart J."},{"key":"2021113011163418200_B79","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1111\/j.1440-1797.2011.01467.x","article-title":"Urinary angiotensin-converting enzyme 2 in patients with CKD","volume":"16","author":"Mizuiri","year":"2011","journal-title":"Nephrology (Carlton)"},{"key":"2021113011163418200_B80","doi-asserted-by":"publisher","first-page":"F749","DOI":"10.1152\/ajprenal.00383.2009","article-title":"Reciprocal changes in renal ACE\/ANG II and ACE2\/ANG 1-7 are associated with enhanced collecting duct renin in Goldblatt hypertensive rats","volume":"300","author":"Prieto","year":"2011","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B81","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1038\/ki.2008.497","article-title":"Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease","volume":"74","author":"Reich","year":"2008","journal-title":"Kidney Int."},{"key":"2021113011163418200_B82","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cardfail.2009.09.005","article-title":"Plasma ACE2 activity is an independent prognostic marker in Chagas\u2019 disease and equally potent as BNP","volume":"16","author":"Wang","year":"2010","journal-title":"J. Card. Fail."},{"key":"2021113011163418200_B83","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s00436-019-06485-6","article-title":"Renin angiotensin system molecules and nitric oxide local interactions in the adrenal gland of Trypanosoma cruzi infected rats","volume":"119","author":"Miranda","year":"2020","journal-title":"Parasitol. Res."},{"key":"2021113011163418200_B84","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.actatropica.2019.03.020","article-title":"Interactions between local renin angiotensin system and nitric oxide in the brain of Trypanosoma cruzi infected rats","volume":"194","author":"Miranda","year":"2019","journal-title":"Acta Trop."},{"key":"2021113011163418200_B85","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1097\/FJC.0000000000000307","article-title":"ACE2 and microbiota: emerging targets for cardiopulmonary disease therapy","volume":"66","author":"Cole-Jeffrey","year":"2015","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113011163418200_B86","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1161\/HYPERTENSIONAHA.120.15360","article-title":"Gnotobiotic rats reveal that gut microbiota regulates colonic mRNA of Ace2, the receptor for SARS-CoV-2 infectivity","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"key":"2021113011163418200_B87","doi-asserted-by":"publisher","first-page":"C420","DOI":"10.1152\/ajpcell.00409.2004","article-title":"Distinct roles for ANG II and ANG-(1-7) in the regulation of angiotensin-converting enzyme 2 in rat astrocytes","volume":"290","author":"Gallagher","year":"2006","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2021113011163418200_B88","doi-asserted-by":"publisher","first-page":"H2373","DOI":"10.1152\/ajpheart.00426.2008","article-title":"Regulation of ACE2 in cardiac myocytes and fibroblasts","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011163418200_B89","doi-asserted-by":"publisher","first-page":"C1169","DOI":"10.1152\/ajpcell.00145.2008","article-title":"MAP kinase\/phosphatase pathway mediates the regulation of ACE2 by angiotensin peptides","volume":"295","author":"Gallagher","year":"2008","journal-title":"Am. J. Physiol. Cell Physiol."},{"key":"2021113011163418200_B90","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.peptides.2012.01.020","article-title":"Angiotensin-(1-7) abrogates mitogen-stimulated proliferation of cardiac fibroblasts","volume":"34","author":"McCollum","year":"2012","journal-title":"Peptides"},{"key":"2021113011163418200_B91","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.freeradbiomed.2013.08.183","article-title":"Angiotensin-(1-7) prevents radiation-induced inflammation in rat primary astrocytes through regulation of MAP kinase signaling","volume":"65","author":"Moore","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"2021113011163418200_B92","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of angiotensin-converting enzyme 2 after myocardial infarction by blockade of angiotensin II receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"2021113011163418200_B93","doi-asserted-by":"publisher","first-page":"H2166","DOI":"10.1152\/ajpheart.00061.2006","article-title":"Effect of angiotensin II blockade on a new congenic model of hypertension derived from transgenic Ren-2 rats","volume":"291","author":"Jessup","year":"2006","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011163418200_B94","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1161\/HYPERTENSIONAHA.112.201889","article-title":"Hemodynamic and hormonal changes to dual renin-angiotensin system inhibition in experimental hypertension","volume":"61","author":"Moniwa","year":"2013","journal-title":"Hypertension"},{"key":"2021113011163418200_B95","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1291\/hypres.31.553","article-title":"Increased expression of angiotensin converting enzyme 2 in conjunction with reduction of neointima by angiotensin II type 1 receptor blockade","volume":"31","author":"Igase","year":"2008","journal-title":"Hypertens. Res."},{"key":"2021113011163418200_B96","doi-asserted-by":"publisher","first-page":"H1013","DOI":"10.1152\/ajpheart.00068.2005","article-title":"Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats","volume":"289","author":"Igase","year":"2005","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"2021113011163418200_B97","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1291\/hypres.29.865","article-title":"Olmesartan is an angiotensin II receptor blocker with an inhibitory effect on angiotensin-converting enzyme","volume":"29","author":"Agata","year":"2006","journal-title":"Hypertens. Res."},{"key":"2021113011163418200_B98","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.3892\/mmr.2017.6848","article-title":"The ACE2-Ang (1-7)-Mas receptor axis attenuates cardiac remodeling and fibrosis in post-myocardial infarction","volume":"16","author":"Wang","year":"2017","journal-title":"Mol. Med. Rep."},{"key":"2021113011163418200_B99","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.regpep.2010.09.005","article-title":"Telmisartan attenuates aortic hypertrophy in hypertensive rats by the modulation of ACE2 and profilin-1 expression","volume":"166","author":"Zhong","year":"2011","journal-title":"Regul. Pept."},{"key":"2021113011163418200_B100","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/j.1440-1681.2009.05302.x","article-title":"Upregulation of angiotensin-converting enzyme (ACE) 2 in hepatic fibrosis by ACE inhibitors","volume":"37","author":"Huang","year":"2010","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"2021113011163418200_B101","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1042\/CS20090318","article-title":"Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition","volume":"118","author":"Velkoska","year":"2010","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011163418200_B102","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1097\/SHK.0000000000000302","article-title":"Angiotensin-converting enzyme inhibition attenuates lipopolysaccharide-induced lung injury by regulating the balance between angiotensin-converting enzyme and angiotensin-converting enzyme 2 and inhibiting mitogen-activated protein kinase activation","volume":"43","author":"Li","year":"2015","journal-title":"Shock"},{"key":"2021113011163418200_B103","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1097\/FJC.0000000000000374","article-title":"Olmesartan inhibits cardiac hypertrophy in mice overexpressing renin independently of blood pressure: its beneficial effects on ACE2\/Ang(1-7)\/Mas axis and NADPH oxidase expression","volume":"67","author":"Tanno","year":"2016","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113011163418200_B104","doi-asserted-by":"publisher","first-page":"F398","DOI":"10.1152\/ajprenal.90488.2008","article-title":"Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan","volume":"296","author":"Soler","year":"2009","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B105","doi-asserted-by":"publisher","first-page":"F1523","DOI":"10.1152\/ajprenal.00426.2009","article-title":"Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease","volume":"298","author":"Dilauro","year":"2010","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B106","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1042\/CS20120162","article-title":"Combination renin-angiotensin system blockade and angiotensin-converting enzyme 2 in experimental myocardial infarction: implications for future therapeutic directions","volume":"123","author":"Burchill","year":"2012","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011163418200_B107","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000365093","article-title":"Comparative effects of a novel angiotensin-converting enzyme inhibitor versus captopril on plasma angiotensins after myocardial infarction","volume":"94","author":"Flores-Monroy","year":"2014","journal-title":"Pharmacology"},{"key":"2021113011163418200_B108","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1113\/expphysiol.2007.041855","article-title":"Differential regulation of renal angiotensin-converting enzyme (ACE) and ACE2 during ACE inhibition and dietary sodium restriction in healthy rats","volume":"93","author":"Hamming","year":"2008","journal-title":"Exp. Physiol."},{"key":"2021113011163418200_B109","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1681\/ASN.2020050667","article-title":"Kidney and lung ACE2 expression after an ACE inhibitor or an Ang II receptor blocker: implications for COVID-19","volume":"31","author":"Wysocki","year":"2020","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011163418200_B110","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.kint.2016.09.032","article-title":"Angiotensin-converting enzyme 2 amplification limited to the circulation does not protect mice from development of diabetic nephropathy","volume":"91","author":"Wysocki","year":"2017","journal-title":"Kidney Int."},{"issue":"6","key":"2021113011163418200_B111","doi-asserted-by":"publisher","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-angiotensin system blockers and the COVID-19 pandemic: at present there is no evidence to abandon renin-angiotensin system blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"2021113011163418200_B112","doi-asserted-by":"publisher","first-page":"357","DOI":"10.2217\/14796678.4.4.357","article-title":"Olmesartan for the treatment of arterial hypertension","volume":"4","author":"Schindler","year":"2008","journal-title":"Future Cardiol."},{"key":"2021113011163418200_B113","doi-asserted-by":"publisher","first-page":"e103909","DOI":"10.1371\/journal.pone.0103909","article-title":"Statin treatment in hypercholesterolemic men does not attenuate angiotensin II-induced venoconstriction","volume":"9","author":"Schindler","year":"2014","journal-title":"PLoS ONE"},{"key":"2021113011163418200_B114","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1291\/hypres.21.267","article-title":"Role of nitric oxide in the evolution of renal ischemia in two-kidney, one-clip renovascular hypertension","volume":"21","author":"Nakamoto","year":"1998","journal-title":"Hypertens. Res."},{"key":"2021113011163418200_B115","doi-asserted-by":"publisher","first-page":"F353","DOI":"10.1152\/ajprenal.00144.2004","article-title":"The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules","volume":"288","author":"Li","year":"2005","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B116","doi-asserted-by":"publisher","first-page":"F82","DOI":"10.1152\/ajprenal.00139.2006","article-title":"Angiotensin metabolism in renal proximal tubules, urine, and serum of sheep: evidence for ACE2-dependent processing of angiotensin II","volume":"292","author":"Shaltout","year":"2007","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B117","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/j.cardfail.2009.01.014","article-title":"Soluble angiotensin-converting enzyme 2 in human heart failure: relation with myocardial function and clinical outcomes","volume":"15","author":"Epelman","year":"2009","journal-title":"J. Card. Fail."},{"key":"2021113011163418200_B118","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary angiotensin-converting enzyme 2 in hypertensive patients may be increased by olmesartan, an angiotensin II receptor blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"2021113011163418200_B119","first-page":"625","article-title":"Effects of angiotensin converting enzyme inhibitor on the expression of angiotensin converting enzyme 2 in atrium of patients with atrial fibrillation","volume":"35","author":"Hu","year":"2007","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"2021113011163418200_B120","first-page":"224","article-title":"Study on up-regulation of the expression of angiotensin-converting enzyme-2 in human umbilical vein endothelial cells by telmisartan","volume":"18","author":"Wang","year":"2006","journal-title":"Zhongguo Wei Zhong Bing Ji Jiu Yi Xue"},{"key":"2021113011163418200_B121","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"issue":"3","key":"2021113011163418200_B122","doi-asserted-by":"publisher","first-page":"e0213096","DOI":"10.1371\/journal.pone.0213096","article-title":"Circulating angiotensin peptides levels in Acute Respiratory Distress Syndrome correlate with clinical outcomes: a pilot study","volume":"14","author":"Reddy","year":"2019","journal-title":"PLoS ONE"},{"key":"2021113011163418200_B123","article-title":"COVID-19: AHA Guidance on Hypertension, Latest on Angiotensin Link 2020","author":"Hughes","year":"2020","journal-title":"Medscape Medical News"},{"issue":"11","key":"2021113011163418200_B124","doi-asserted-by":"publisher","first-page":"4623","DOI":"10.1007\/s11695-020-04741-8","article-title":"Recommendations to manage patients for bariatric surgery in the COVID-19 pandemic: experience from China","volume":"30","author":"Dong","year":"2020","journal-title":"Obes. Surg."},{"key":"2021113011163418200_B125","first-page":"e142","article-title":"Response by Zhang et al to Letter regarding article, \u201cAssociation of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19\u201d","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"2021113011163418200_B126","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"issue":"2","key":"2021113011163418200_B127","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1161\/HYPERTENSIONAHA.120.15622","article-title":"Comparative impacts of angiotensin converting enzyme inhibitors versus angiotensin II receptor blockers on the risk of COVID-19 mortality","volume":"76","author":"Zhou","year":"2020","journal-title":"Hypertension"},{"key":"2021113011163418200_B128","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1056\/NEJMc2021225","article-title":"Cardiovascular disease, drug therapy, and mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2021113011163418200_B129","doi-asserted-by":"publisher","first-page":"2582","DOI":"10.1056\/NEJMc2021225","article-title":"Retraction: cardiovascular disease, drug therapy, and mortality in Covid-19","volume":"382","author":"Mehra","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"2021113011163418200_B130","doi-asserted-by":"publisher","DOI":"10.1093\/ehjcvp\/pvaa062","article-title":"Association between renin-angiotensin system inhibitors and COVID-19 complications","author":"Liabeuf","year":"2020","journal-title":"Eur. Heart J. Cardiovasc. Pharmacother."},{"key":"2021113011163418200_B131","doi-asserted-by":"publisher","first-page":"1822","DOI":"10.1038\/s41591-019-0675-0","article-title":"Chronic inflammation in the etiology of disease across the life span","volume":"25","author":"Furman","year":"2019","journal-title":"Nat. Med."},{"key":"2021113011163418200_B132","doi-asserted-by":"publisher","first-page":"1456","DOI":"10.1161\/CIRCRESAHA.120.317015","article-title":"Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2","volume":"126","author":"Gheblawi","year":"2020","journal-title":"Circ. Res."},{"key":"2021113011163418200_B133","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11886-008-0073-6","article-title":"Is hypertension an immunologic disease?","volume":"10","author":"Harrison","year":"2008","journal-title":"Curr. Cardiol. Rep."},{"key":"2021113011163418200_B134","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1161\/HYPERTENSIONAHA.110.163576","article-title":"Inflammation, immunity, and hypertension","volume":"57","author":"Harrison","year":"2011","journal-title":"Hypertension"},{"key":"2021113011163418200_B135","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1097\/HJH.0000000000000042","article-title":"Inflammation, immunity and development of essential hypertension","volume":"32","author":"Schiffrin","year":"2014","journal-title":"J. Hypertens."},{"key":"2021113011163418200_B136","first-page":"149","article-title":"Biphasic changes in thymus structure during evolving renal hypertension","volume":"55","author":"Chatelain","year":"1978","journal-title":"Clin. Sci. Mol. Med."},{"key":"2021113011163418200_B137","first-page":"737","article-title":"Lymphoid alterations and impaired T lymphocyte reactivity in experimental renal hypertension","volume":"95","author":"Chatelain","year":"1980","journal-title":"J. Lab. Clin. Med."},{"key":"2021113011163418200_B138","first-page":"775","article-title":"Raised levels of immunoglobulins in serum of hypertensive patients","volume":"81","author":"Olsen","year":"1973","journal-title":"Acta Pathol. Microbiol. Scand. B Microbiol. Immunol."},{"key":"2021113011163418200_B139","first-page":"498","article-title":"Delayed hypersensitivity directed against arterial antigens in the hypertensive disease in man","volume":"81","author":"Olsen","year":"1973","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"key":"2021113011163418200_B140","first-page":"141s","article-title":"The thymus of spontaneously hypertensive rats: light-and electron-microscopic studies","volume":"45","author":"Rojo-Ortega","year":"1973","journal-title":"Clin. Sci. Mol. Med. Suppl."},{"key":"2021113011163418200_B141","first-page":"539","article-title":"The importance of thymus in the pathogenesis of the chronic phase of hypertension in mice following partial infarction of the kidney","volume":"85","author":"Svendsen","year":"1977","journal-title":"Acta Pathol. Microbiol. Scand. A"},{"key":"2021113011163418200_B142","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1159\/000179322","article-title":"Autoimmune factors associated with infarction of the kidney","volume":"1","author":"White","year":"1964","journal-title":"Nephron"},{"key":"2021113011163418200_B143","doi-asserted-by":"publisher","first-page":"2449","DOI":"10.1084\/jem.20070657","article-title":"Role of the T cell in the genesis of angiotensin II induced hypertension and vascular dysfunction","volume":"204","author":"Guzik","year":"2007","journal-title":"J. Exp. Med."},{"key":"2021113011163418200_B144","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1111\/j.1365-2141.2004.04998.x","article-title":"Renin-angiotensin system expression in rat bone marrow haematopoietic and stromal cells","volume":"126","author":"Strawn","year":"2004","journal-title":"Br. J. Haematol."},{"key":"2021113011163418200_B145","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1161\/HYPERTENSIONAHA.119.13754","article-title":"Noncanonical mechanisms for direct bone marrow generating Ang II (Angiotensin II) predominate in CD68 positive myeloid lineage cells","volume":"75","author":"Yamashita","year":"2020","journal-title":"Hypertension"},{"key":"2021113011163418200_B146","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1111\/j.1749-6632.1994.tb12036.x","article-title":"Role of platelets and leukocytes in modulation of vascular tone","volume":"714","author":"Kaul","year":"1994","journal-title":"Ann. N.Y. Acad. Sci."},{"key":"2021113011163418200_B147","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1161\/01.CIR.91.4.1129","article-title":"Evidence that angiotensin II is present in human monocytes","volume":"91","author":"Kitazono","year":"1995","journal-title":"Circulation"},{"key":"2021113011163418200_B148","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1136\/hrt.2003.029397","article-title":"Novel NAD(P)H oxidases in the cardiovascular system","volume":"90","author":"Griendling","year":"2004","journal-title":"Heart"},{"key":"2021113011163418200_B149","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.1089\/ars.2006.8.1443","article-title":"NADPH oxidases: new regulators of old functions","volume":"8","author":"Griendling","year":"2006","journal-title":"Antioxid. Redox Signal."},{"key":"2021113011163418200_B150","doi-asserted-by":"publisher","first-page":"672","DOI":"10.2174\/1573406410666140318111328","article-title":"Inflammation markers in essential hypertension","volume":"10","author":"Tsounis","year":"2014","journal-title":"Med. Chem."},{"key":"2021113011163418200_B151","doi-asserted-by":"publisher","first-page":"1259","DOI":"10.1042\/CS20200492","article-title":"Covid-19: the renin-angiotensin system imbalance hypothesis","volume":"134","author":"Lanza","year":"2020","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011163418200_B152","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus-induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"2021113011163418200_B153","doi-asserted-by":"publisher","first-page":"914","DOI":"10.1093\/qjmed\/hcz206","article-title":"Angiotensin-converting enzyme 2 attenuates inflammatory response and oxidative stress in hyperoxic lung injury by regulating NF-kappaB and Nrf2 pathways","volume":"112","author":"Fang","year":"2019","journal-title":"QJM"},{"key":"2021113011163418200_B154","doi-asserted-by":"publisher","first-page":"717","DOI":"10.1161\/CIRCULATIONAHA.110.955369","article-title":"Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction","volume":"122","author":"Zhong","year":"2010","journal-title":"Circulation"},{"key":"2021113011163418200_B155","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1161\/HYPERTENSIONAHA.110.164244","article-title":"Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2","volume":"57","author":"Zhong","year":"2011","journal-title":"Hypertension"},{"key":"2021113011163418200_B156","doi-asserted-by":"publisher","first-page":"10505","DOI":"10.1096\/fj.202001020R","article-title":"The ACE2-deficient mouse: a model for a cytokine storm-driven inflammation","volume":"34","author":"Wang","year":"2020","journal-title":"FASEB J."},{"key":"2021113011163418200_B157","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1097\/SHK.0000000000000633","article-title":"Pulmonary angiotensin-converting enzyme 2 (ACE2) and inflammatory lung disease","volume":"46","author":"Jia","year":"2016","journal-title":"Shock"},{"key":"2021113011163418200_B158","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1097\/MNH.0b013e3282f945c2","article-title":"New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2 - a potential target for treatment of hypertension and diabetic nephropathy","volume":"17","author":"Batlle","year":"2008","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"2021113011163418200_B159","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human intestine luminal ACE2 and amino acid transporter expression increased by ACE-inhibitors","volume":"47","author":"Vuille-dit-Bille","year":"2015","journal-title":"Amino Acids"},{"key":"2021113011163418200_B160","doi-asserted-by":"publisher","first-page":"766","DOI":"10.14309\/ajg.0000000000000620","article-title":"Clinical characteristics of COVID-19 patients with digestive symptoms in Hubei, China: a descriptive, cross-sectional, multicenter study","volume":"115","author":"Pan","year":"2020","journal-title":"Am. J. Gastroenterol."},{"key":"2021113011163418200_B161","first-page":"30272","article-title":"SEDAR-SEMICYUC consensus recommendations on the management of haemostasis disorders in severely ill patients with COVID-19 infection","volume":"S0210-569","author":"Llau","year":"2020","journal-title":"Rev. Esp. Anestesiol. Reanim."},{"key":"2021113011163418200_B162","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1093\/eurheartj\/ehaa487","article-title":"Renin-angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs","volume":"41","author":"Ruilope","year":"2020","journal-title":"Eur. Heart J."},{"key":"2021113011163418200_B163","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0140-6736(20)31131-4","article-title":"Hypertension, renin-angiotensin-aldosterone system inhibition, and COVID-19","volume":"395","author":"Williams","year":"2020","journal-title":"Lancet"},{"key":"2021113011163418200_B164","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality","author":"Fosbol","year":"2020","journal-title":"JAMA"},{"key":"2021113011163418200_B165","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1113\/expphysiol.2007.040386","article-title":"Acute kidney injury in the rat causes cardiac remodelling and increases angiotensin-converting enzyme 2 expression","volume":"93","author":"Burchill","year":"2008","journal-title":"Exp. Physiol."},{"key":"2021113011163418200_B166","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1177\/1753944708098691","article-title":"Olmesartan improves left ventricular function in pressure-overload hypertrophied rat heart by blocking angiotensin II receptor with synergic effects of upregulation of angiotensin converting enzyme 2","volume":"3","author":"Kaiqiang","year":"2009","journal-title":"Ther. Adv. Cardiovasc. Dis."},{"key":"2021113011163418200_B167","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.taap.2010.02.009","article-title":"Losartan attenuates chronic cigarette smoke exposure-induced pulmonary arterial hypertension in rats: possible involvement of angiotensin-converting enzyme-2","volume":"245","author":"Han","year":"2010","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"2021113011163418200_B168","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1093\/ajh\/hps090","article-title":"Predominance of AT(1) blockade over mas-mediated angiotensin-(1-7) mechanisms in the regulation of blood pressure and renin-angiotensin system in mRen2.Lewis rats","volume":"26","author":"Varagic","year":"2013","journal-title":"Am. J. Hypertens."},{"key":"2021113011163418200_B169","doi-asserted-by":"publisher","first-page":"e28501","DOI":"10.1371\/journal.pone.0028501","article-title":"Chymase-dependent generation of angiotensin II from angiotensin-(1-12) in human atrial tissue","volume":"6","author":"Ahmad","year":"2011","journal-title":"PLoS ONE"},{"key":"2021113011163418200_B170","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1007\/s11906-014-0429-9","article-title":"Angiotensin-: a chymase-mediated cellular angiotensin II substrate","volume":"16","author":"Ahmad","year":"2014","journal-title":"Curr. Hypertens. Rep."},{"key":"2021113011163418200_B171","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.bbrc.2016.07.100","article-title":"Primacy of cardiac chymase over angiotensin converting enzyme as an angiotensin-(1-12) metabolizing enzyme","volume":"478","author":"Ahmad","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"2021113011163418200_B172","doi-asserted-by":"publisher","first-page":"e15759","DOI":"10.1371\/journal.pone.0015759","article-title":"Uptake and metabolism of the novel peptide angiotensin-(1-12) by neonatal cardiac myocytes","volume":"6","author":"Ahmad","year":"2011","journal-title":"PLoS ONE"},{"key":"2021113011163418200_B173","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jash.2012.12.003","article-title":"Chymase mediates angiotensin-(1-12) metabolism in normal human hearts","volume":"7","author":"Ahmad","year":"2013","journal-title":"J. Am. Soc. Hypertens."},{"key":"2021113011163418200_B174","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1161\/01.HYP.31.1.362","article-title":"Metabolism of angiotensin-(1-7) by angiotensin-converting enzyme","volume":"31","author":"Chappell","year":"1998","journal-title":"Hypertension"},{"key":"2021113011163418200_B175","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S1054-3589(10)59007-0","article-title":"Advances in the renin angiotensin system focus on angiotensin-converting enzyme 2 and angiotensin-(1-7)","volume":"59","author":"Ferrario","year":"2010","journal-title":"Adv. Pharmacol."},{"key":"2021113011163418200_B176","doi-asserted-by":"publisher","first-page":"1349","DOI":"10.1111\/j.1523-1755.2002.kid559.x","article-title":"Vasopeptidase inhibition and Ang-(1-7) in the spontaneously hypertensive rat","volume":"62","author":"Ferrario","year":"2002","journal-title":"Kidney Int."},{"key":"2021113011163418200_B177","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1681\/ASN.V991716","article-title":"Novel angiotensin peptides regulate blood pressure, endothelial function, and natriuresis","volume":"9","author":"Ferrario","year":"1998","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011163418200_B178","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1097\/00004872-199107000-00008","article-title":"Evidence that prolyl endopeptidase participates in the processing of brain angiotensin","volume":"9","author":"Welches","year":"1991","journal-title":"J. Hypertens."},{"issue":"2","key":"2021113011163418200_B179","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/jcdd6020014","article-title":"An update on the tissue renin angiotensin system and its role in physiology and pathology","volume":"6","author":"Nehme","year":"2019","journal-title":"J. Cardiovasc. Dev. Dis."},{"key":"2021113011163418200_B180","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1042\/CS20130400","article-title":"An evolving story of angiotensin-II-forming pathways in rodents and humans","volume":"126","author":"Ferrario","year":"2014","journal-title":"Clin. Sci. (Lond.)"},{"key":"2021113011163418200_B181","doi-asserted-by":"publisher","first-page":"e40110","DOI":"10.1371\/journal.pone.0040110","article-title":"Cardiac kallikrein-kinin system is upregulated in chronic volume overload and mediates an inflammatory induced collagen loss","volume":"7","author":"Wei","year":"2012","journal-title":"PLoS ONE"},{"key":"2021113011163418200_B182","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s11906-002-0042-1","article-title":"Angiotensin II-mediated signal transduction pathways","volume":"4","author":"Saito","year":"2002","journal-title":"Curr. Hypertens. Rep."},{"key":"2021113011163418200_B183","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1161\/01.HYP.37.4.1141","article-title":"Angiotensin-(1-7) downregulates the angiotensin II type 1 receptor in vascular smooth muscle cells","volume":"37","author":"Clark","year":"2001","journal-title":"Hypertension"},{"key":"2021113011163418200_B184","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1097\/00005344-200007000-00015","article-title":"Evidence that prostaglandins mediate the antihypertensive actions of angiotensin-(1-7) during chronic blockade of the renin-angiotensin system","volume":"36","author":"Iyer","year":"2000","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"2021113011163418200_B185","doi-asserted-by":"publisher","first-page":"II49","DOI":"10.1161\/01.HYP.19.2_Suppl.II49","article-title":"Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Characterization of receptors","volume":"19","author":"Jaiswal","year":"1992","journal-title":"Hypertension"},{"key":"2021113011163418200_B186","first-page":"R1000","article-title":"Characterization of angiotensin receptors mediating prostaglandin synthesis in C6 glioma cells","volume":"260","author":"Jaiswal","year":"1991","journal-title":"Am. J. Physiol."},{"key":"2021113011163418200_B187","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1161\/01.HYP.0000090322.55782.30","article-title":"Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)","volume":"42","author":"Tallant","year":"2003","journal-title":"Hypertension"},{"key":"2021113011163418200_B188","doi-asserted-by":"publisher","first-page":"335","DOI":"10.2217\/14796678.2.3.335","article-title":"Cardioprotective role for angiotensin-(1-7) and angiotensin converting enzyme 2 in the heart","volume":"2","author":"Tallant","year":"2006","journal-title":"Future Cardiol."},{"key":"2021113011163418200_B189","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.cardiores.2007.04.007","article-title":"Angiotensin II-mediated oxidative stress and inflammation mediate the age-dependent cardiomyopathy in ACE2 null mice","volume":"75","author":"Oudit","year":"2007","journal-title":"Cardiovasc. Res."},{"key":"2021113011163418200_B190","first-page":"1301","article-title":"The anti-inflammatory potential of ACE2\/Angiotensin-(1-7)\/Mas receptor axis: evidence from basic and clinical research","volume":"18","author":"Prestes","year":"2016","journal-title":"Curr. Drug Targets"},{"key":"2021113011163418200_B191","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2174\/0929866524666170818160809","article-title":"Renin angiotensin system and cytokines in chronic kidney disease: clinical and experimental evidence","volume":"24","author":"Saldanha da Silva","year":"2017","journal-title":"Protein Pept. Lett."},{"key":"2021113011163418200_B192","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.cellimm.2014.12.001","article-title":"Sex-specific immune modulation of primary hypertension","volume":"294","author":"Sandberg","year":"2015","journal-title":"Cell. Immunol."},{"key":"2021113011163418200_B193","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s11906-013-0361-4","article-title":"Dysfunctional brain-bone marrow communication: a paradigm shift in the pathophysiology of hypertension","volume":"15","author":"Santisteban","year":"2013","journal-title":"Curr. Hypertens. Rep."},{"key":"2021113011163418200_B194","doi-asserted-by":"publisher","first-page":"F1197","DOI":"10.1152\/ajprenal.00633.2014","article-title":"Memories that last in hypertension","volume":"308","author":"Itani","year":"2015","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"2021113011163418200_B195","doi-asserted-by":"publisher","first-page":"e67868","DOI":"10.1371\/journal.pone.0067868","article-title":"Interleukin-6 mediates angiotensinogen gene expression during liver regeneration","volume":"8","author":"Lai","year":"2013","journal-title":"PLoS ONE"},{"key":"2021113011163418200_B196","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1097\/00045391-200401000-00010","article-title":"Renin-angiotensin system as a therapeutic target in managing atherosclerosis","volume":"11","author":"Ferrario","year":"2004","journal-title":"Am. J. Ther."},{"key":"2021113011163418200_B197","doi-asserted-by":"publisher","first-page":"1093","DOI":"10.1681\/ASN.2006070707","article-title":"Human T and natural killer cells possess a functional renin-angiotensin system: further mechanisms of angiotensin II-induced inflammation","volume":"18","author":"Jurewicz","year":"2007","journal-title":"J. Am. Soc. Nephrol."},{"key":"2021113011163418200_B198","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1161\/ATVBAHA.110.221614","article-title":"Angiotensin-converting enzyme 2 deficiency in whole body or bone marrow-derived cells increases atherosclerosis in low-density lipoprotein receptor-\/- mice","volume":"31","author":"Thatcher","year":"2011","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"2021113011163418200_B199","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1161\/CIRCULATIONAHA.117.029589","article-title":"Increased inflammation in pericardial fluid persists 48 hours after cardiac surgery","volume":"136","author":"Butts","year":"2017","journal-title":"Circulation"},{"key":"2021113011163418200_B200","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1161\/CIRCRESAHA.117.310978","article-title":"Multifunctional role of chymase in acute and chronic tissue injury and remodeling","volume":"122","author":"Dell\u2019Italia","year":"2018","journal-title":"Circ. Res."}],"container-title":["Clinical Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/134\/19\/2645\/895140\/cs-2020-0901c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/portlandpress.com\/clinsci\/article-pdf\/134\/19\/2645\/895140\/cs-2020-0901c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,16]],"date-time":"2024-08-16T00:17:28Z","timestamp":1723767448000},"score":1,"resource":{"primary":{"URL":"https:\/\/portlandpress.com\/clinsci\/article\/134\/19\/2645\/226685\/Twenty-years-of-progress-in-angiotensin-converting"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":200,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2020,10,16]]}},"URL":"https:\/\/doi.org\/10.1042\/cs20200901","relation":{},"ISSN":["0143-5221","1470-8736"],"issn-type":[{"value":"0143-5221","type":"print"},{"value":"1470-8736","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,10]]},"published":{"date-parts":[[2020,10]]}}}